x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BioTech Nation ... with Dr. Moira Gunn

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for

science life sciences

All Episodes

22:38

Gliobastoma + New View on Clinical Trials... Dr....

BioTech Nation ... with Dr. Moira Gunn ·

2023/08/16

Glioblastoma is the most aggressive form of brain cancer, and progress in treating Glioblastoma has been elusive. Now, Toronto-based Medicenna has completed a successful Phase 2 with its innovative drug, and is now deep into planning the Phase 3 Trial. Also of interest, the FDA agreed to an unprecedented approach in Phase 2, which not only yields better science, but reduces the cost of the clinical trials themselves. To be sure, this approach will be carried forward into Phase 3. Dr. Fahar

en

14:40

Innovation in Head & Neck Cancers!!! Dr. Mark Newman,...

BioTech Nation ... with Dr. Moira Gunn ·

2023/08/09

In this week's BioTech Nation, we discuss Geovax, a company working on a novel approach to treat head and neck cancers, which are often difficult to treat after standard options have been exhausted. Geovax is developing A2 component therapy, using an enzyme delivered directly to the tumor by a needle injection, followed by an infusion of an inactive form of a chemotherapeutic drug, which becomes toxic to the tumors when processed by the enzyme. The treatment aims to localize the effects,

en

9:54

We Still Can't Ignore Long Covid... Dr. Jeffrey...

BioTech Nation ... with Dr. Moira Gunn ·

2023/08/02

In this week's episode of Biotech Nation, Dr. Jeffrey Cleland, the President and CEO of Ashvattha Therapeutics, discusses their drug development efforts to address long COVID. They discuss the definition of long COVID by the World Health Organization, the prevalence of the condition, and the chronic inflammation that occurs in the body, including the brain. Dr. Cleland explains how their nanomedicine approach aims to selectively target and turn off reactive inflammatory cells, potentially

en

10:21

Can The Time Needed for CAR-T be shortened? EXUMA...

BioTech Nation ... with Dr. Moira Gunn ·

2023/07/26

In this week's episode of Biotech Nation, Dr. Greg Frost, CEO of Exuma Biotech, discusses their innovative approaches to cancer treatment. They are working on a method to shorten the time and eliminate hospital stays for CAR-T therapy, while also developing a new technology called G-car that combines T cells and NK cells to create a more gentle and effective cancer therapy.

en

24:21

Temporal Lobe Epilepsy - TLE - Will Cell Therapy...

BioTech Nation ... with Dr. Moira Gunn ·

2023/07/19

A new cell therapy, just entering human clinical trials. It focuses on a particular type of Epilepsy - Temporal Lobe Epilepsy. I speak with Dr. Cory Nicholas, the Co-Founder and CEO of Neurona Therapeutics, about their idea, what they’ve done, and how they plan to approach testing this unprecedented treatment.

en

9:12

New Hope For Glaucoma... Dr. Chris Nave, Managing...

BioTech Nation ... with Dr. Moira Gunn ·

2023/07/12

Join us as Dr. Chris Nave, the managing director of Brandon Capital and Chair of PolyActiva, reveals groundbreaking advancements in eye treatments on this week's episode of Biotech Nation! Discover how their innovative technology is revolutionizing the way we deliver drugs to the eye, offering extended therapy periods and eliminating the need for frequent injections or daily drops. Don't miss out on this eye-opening discussion about the future of ophthalmology and the potential to transform

en

16:36

The Beauty Contest... Winner Goes to Phase I - Dr....

BioTech Nation ... with Dr. Moira Gunn ·

2023/07/05

Join Dr. Richard Austin, Founder and CEO of Reglagene, as he reveals the intense process of selecting the most promising drug candidate for treating brain cancer. Delve into the intriguing world of the "Bake Off" or "beauty contest" where molecules compete to be the breakthrough therapy in human clinical trials. Discover the challenges of penetrating the blood-brain barrier and the quest to revolutionize brain cancer treatment.

en

19:20

Sticky Proteins??? Alzheimer's, Parkinson's, and...

BioTech Nation ... with Dr. Moira Gunn ·

2023/06/28

This week we explore the commonalities among neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS. Dr. Maria Macccecchini, Founder and CEO of Annovis Bio, discusses the role of sticky proteins in these diseases and how her company is developing a drug to prevent the aggregation of these proteins. The episode also touches on their ongoing clinical trials for Alzheimer's and Parkinson's and their potential application in treating traumatic brain injuries.

en

49:33

When Your Distant Cousins ID You For Murder… Ed...

BioTech Nation ... with Dr. Moira Gunn ·

2023/06/21

Moira speaks with Pulitzer Prize-winning author, Ed Humes. His latest is “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double Murder.” We get an object lesson in the Three Ages of DNA, and while it reads like a fast-paced Cold Case on steroids – it provides details no fiction writer would dare to make up, like the unexpected involvement of the famous true crimes writer, Ann Rule, and a person whose DNA skills are familiar to fans of the PBS documentary series, “Finding

en

25:13

Are Fibroblasts All Over My Body??? Dr. Hamid Khoja,...

BioTech Nation ... with Dr. Moira Gunn ·

2023/06/14

Dr. Hamid Khoja, Chief Scientific Officer of Fibro Biologics, discusses the potential of fibroblasts in regenerative medicine, highlighting their abundance and diverse functions in the body. He shares insights from their ongoing human clinical trials, including the use of fibroblasts for treating degenerative disc disease and multiple sclerosis. Dr. Khoja also mentions their promising findings in animal studies related to diabetic foot ulcers.

en

22:24

Engineering Viruses to Treat Solid Tumors... Dr. Paul...

BioTech Nation ... with Dr. Moira Gunn ·

2023/06/06

Dr. Paul Peter Tack, CEO of Candel Therapeutics, unveils their groundbreaking approach to cancer treatments using engineered viruses. Discover how these viruses are harnessed to target solid tumors, deliver therapeutic genes, and activate the patient's immune system for a powerful anti-cancer response.

en

27:35

AI Three Different Ways to a New Drug??? Dr. Francois...

BioTech Nation ... with Dr. Moira Gunn ·

2023/05/31

Discover the limitless potential of mRNA engineering as Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, discusses their groundbreaking work in using mRNA to address genetic mutations in diseases like Parkinson's and Alzheimer's, offering hope for effective treatments and prevention strategies. Join us as we delve into the world of mRNA technology and its transformative impact on healthcare.

en

10:29

Fighting the Most Advanced Prostate Cancer... Dr....

BioTech Nation ... with Dr. Moira Gunn ·

2023/05/24

200,000 men at diagnosed each year with Prostate cancer … beginning a journey of many successive treatments. Still, 35,000 men die as a result of prostate cancer. Convergent Therapeutics is focusing on the most advanced, intractable cases of prostate cancer. We speak with, Dr. Philip Kantoff is its Co-Founder, Chief Medical Officer and CEO.

en

13:31

A Different Approach, A New Cancer Drug... Dr. Paul...

BioTech Nation ... with Dr. Moira Gunn ·

2023/05/17

Cancer treatments which work with the immune system are making great strides, with Keytruda from Merck being perhaps the best known. Still there is much work to be done – both in developing unprecedented new treatments, as well as treatments which might combine with our existing treatments to make them even more effective. Triumvera (try-um-VEERA) Immunologics is working on both. Dr. Paul Lammers is its CEO.

en

16:10

Are Your Genes Failing You??? Dr. Noah Davidsohn,...

BioTech Nation ... with Dr. Moira Gunn ·

2023/05/10

Dr. Nolan Davidson, the Co-Founder and Chief Scientific Officer of Rejuvenate Bio, discusses the importance of regulating protein expression and the role it plays in aging. He talks about the three primary genes that drive health and the need to maintain their ideal levels to avoid diseases such as heart disease, liver disease, or kidney disease.

en

25:03

From Illness to Wellness - Can Science Tell Us How...

BioTech Nation ... with Dr. Moira Gunn ·

2023/05/03

Part II - We continue our discussion with Dr. Leroy Hood and Dr. Nathan Price about the subject of their book "The Age of Scientific Wellness", delving into the role of artificial intelligence in healthcare and the ability to mine deep data to deliver hyper-personalized recommendations at a scale never before possible.

en

26:57

From Illness to Wellness - Can Science Tell Us How...

BioTech Nation ... with Dr. Moira Gunn ·

2023/04/26

Dr. Leroy Hood and Dr. Nathan Price delve into the subject of their book "The Age of Scientific Wellness", which highlights the advancements in science that enable the prediction and personalization of healthcare based on an individual's wellness level, and the potential advantages of early diagnosis and treatment of illnesses

en

16:12

25 Years in the Making - Treatment in Schleroderma?...

BioTech Nation ... with Dr. Moira Gunn ·

2023/04/19

Dr. Darren Kelly, a professor and researcher at the University of Melbourne and the Founder and CEO of Certa Therapeutics, tells us about their clinical trials addressing the skin condition: schleroderma. Their unprecedented approach and the results of their latest trial are worth noting.

en

27:38

Fatty Liver, NASH, Cirrhosis - Can They Be Stopped???...

BioTech Nation ... with Dr. Moira Gunn ·

2023/04/12

Did you know that 1 in 4 Americans suffer from fatty liver disease? And that can lead to a more serious condition called Nash, which can ultimately cause cirrhosis of the liver. Hepion Pharmaceuticals is currently in clinical trials to successfully treat Nash. Learn more about how to take care of your liver on today's episode of BioTech Nation with Dr. Robert Foster, CEO of Hepion Pharmaceuticals.

en

20:00

Can AI Discover Drugs Better Than Humans?? Dr. Vimal...

BioTech Nation ... with Dr. Moira Gunn ·

2023/04/05

Discover how their AI technology is revolutionizing drug discovery with Dr. Vimal Mehta, Co-Founder and CEO BioXcel and how this is leading to the approval of their first drug for agitation in bipolar I and II and schizophrenia, and paving the way for new treatments.

en

164 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter